Studies on the role of goat heart galectin-1 as a tool for detecting post-malignant changes in glycosylation pattern

Saudi Journal of Biological Sciences

Volumn 22, Issue 1, 2015, Pages 85-89

  Ashraf, Ghulam Md ^a   Perveen, Asma ^b   Tabrez, Shams ^a   Zaidi, Syed Kashif ^a   Kamal, Mohammad A ^a   Banu, Naheed ^b,c  

^a KING ABDULAZIZ UNIVERSITY   (Saudi Arabia)

^b ALIGARH MUSLIM UNIVERSITY   (India)

^c QASSIM UNIVERSITY   (Saudi Arabia)

Author keywords

Cancer; Glycosylation; Goat heart galectin 1; HOCl; Oxyhemoglobin; Pyrogallol

Indexed keywords

CAPRA HIRCUS; MAMMALIA;

EID: 85027928860     PISSN: 1319562X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.sjbs.2014.07.008     Document Type: Article

References (27)

1. Abou-Seif M.A., Rabia A., Nasr M. Antioxidant status, erythrocyte membrane lipid peroxidation and osmotic fragility in malignant lymphoma patients. Clin. Chem. Lab. Med. 2000, 38:737-742.
2. Ashraf G.M., Bilal N., Suhail N., Hasan S., Banu N. Glycosylation of purified buffalo heart galectin-1 plays crucial role in maintaining its structural and functional integrity. Biochemistry (Mosc.) 2010, 75:1450-1457.
3. Ashraf G.M., Rizvi S., Naqvi S., Suhail N., Bilal N., Hasan S., Tabish M., Banu N. Purification, characterization, structural analysis and protein chemistry of a buffalo heart galectin-1. Amino Acids 2010, 39:1321-1332.
4. Ashraf G.M., Banu N., Ahmad A., Singh L.P., Kumar R. Purification, characterization, sequencing and biological chemistry of galectin-1 purified from Capra hircus (goat) heart. Protein J. 2011, 30:39-51.
5. Baxi B.R., Patel P.S., Adhvaryu S.G., Dayal P.K. Usefulness of serum glycoconjugates in precancerous and cancerous diseases of the oral cavity. Cancer 1991, 67:135-140.
6. Collard C.D., Montalto M.C., Reenstra W.R., Buras J.A., Stahl G.L. Endothelial oxidative stress activates the lectin complement pathway. Am. J. Pathol. 2001, 159:1045-1054.
7. Greco C., Vona R., Cosimelli M., Matarrese P., Straface E., Scordati P., Giannarelli D., Casale V., Assisi D., Mottolese M., Moles A., Malorni W. Cell surface overexpression of galectin-3 and the presence of its ligand 90k in the blood plasma as determinants in colon neoplastic lesions. Glycobiology 2004, 14:783-792.
8. Hajela K., Pande A.H., Sumati Carbohydrate induced modulation of cell membrane. VI. Binding of exogenous lectin induces susceptibility of erythrocytes to free radical damage: a spin label study. FEBS Lett. 1997, 406:255-258.
9. Hasan S.S., Ashraf G.M., Banu N. Galectins - potential targets for cancer therapy. Cancer Lett. 2007, 253:25-33.
10. Hernández-Hernández A., Rodríguez M.C., López-Revuelta A., Sánchez-Gallego J.I., Shnyrov V., Llanillo M., Sánchez-Yagüe J. Alterations in erythrocyte membrane protein composition in advanced non-small cell lung cancer. Blood Cells Mol. Dis. 2006, 36:355-363.
11. Huang C.-S., Tang S.-J., Chung L.-Y., Yu C.-P., Ho J.-Y., Cha T.-L., Hsieh C.-C., Wang H.-H., Sun G.-H., Sun K.-H. Galectin-1 upregulates CXCR4 to promote tumor progression and poor outcome in kidney cancer. J. Am. Soc. Nephrol. 2014, 25(7):1486-1495.
12. Kopitz J., André S., von Reitzenstein C., Versluis K., Kaltner H., Pieters R.J., Wasano K., Kuwabara I., Liu F.-T., Cantz M., Heck A.J.R., Gabius H.-J. Homodimeric galectin-7 (p53-induced gene 1) is a negative growth regulator for human neuroblastoma cells. Oncogene 2003, 22:6277-6288.
13. Laderach D.J., Gentilini L.D., Giribaldi L., Delgado V.C., Nugnes L., Croci D.O., Nakouzi N.A., Sacca P., Casas G., Mazza O., Shipp M.A., Vazquez E., Chauchereau A., Kutok J.L., Rodig S.J., Elola M.T., Compagno D., Rabinovich G.A. A unique galectin signature in human prostate cancer progression suggests galectin-1 as a key target for treatment of advanced disease. Cancer Res. 2013, 73:86-96.
14. Lahm H., André S., Hoeflich A., Kaltner H., Siebert H.-C., Sordat B., von der Lieth C.-W., Wolf E., Gabius H.-J. Tumor galectinology: insights into the complex network of a family of endogenous lectins. Glycoconjugate J. 2004, 20:227-238.
15. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with the folin phenol reagent. J. Biol. Chem. 1951, 193:265-275.
16. Pugalendhi P., Manoharan S., Suresh K., Baskaran N. Genistein and daidzein, in combination, protect cellular integrity during 7,12-dimethylbenz[a]anthracene (DMBA) induced mammary carcinogenesis in Sprague-Dawley rats. Afr. J. Tradit. Complement. Altern. Med. 2010, 8:91-97.
17. Raz A., Lotan R. Lectin-like activities associated with human and murine neoplastic cells. Cancer Res. 1981, 41:3642-3647.
18. Robert W.L., Gusheng W., David B., Zi-Hua L., Hans-Joachim G. Galectin-1 cross-linking of GM1 ganglioside in autoimmune suppression. vol. 1115 2012, 107-121. American Chemical Society.
19. Rorive S., Belot N., Decaestecker C., Lefranc F., Gordower L., Micik S., Maurage C.A., Kaltner H., Ruchoux M.M., Danguy A., Gabius H.J., Salmon I., Kiss R., Camby I. Galectin-1 is highly expressed in human gliomas with relevance for modulation of invasion of tumor astrocytes into the brain parenchyma. Glia 2001, 33:241-255.
20. Rotblat B., Niv H., André S., Kaltner H., Gabius H.-J., Kloog Y. Galectin-1(L11A) predicted from a computed galectin-1 farnesyl-binding pocket selectively inhibits Ras-GTP. Cancer Res. 2004, 64:3112-3118.
21. Shetty R.K.S., Bhandary S.K., Kali A. Significance of serum l-fucose glycoprotein as cancer biomarker in head and neck malignancies without distant metastasis. J. Clin. Diagn. Res. 2013, 7:2818-2820.
22. Song L., Tang J.-W., Owusu L., Sun M.-Z., Wu J., Zhang J. Galectin-3 in cancer. Clin Chim. Acta 2014, 431:185-191.
23. Toivanen A., Ihanus E., Mattila M., Lutz H.U., Gahmberg C.G. Importance of molecular studies on major blood groups - intercellular adhesion molecule-4, a blood group antigen involved in multiple cellular interactions. Biochim. Biophys. Acta 2008, 1780:456-466.
24. Vissers M.C.M., Winterbourn C.C. Oxidative damage to fibronectin: I. The effects of the neutrophil myeloperoxidase system and HOCl. Arch. Biochem. Biophys. 1991, 285:53-59.
25. Vladoiu M.C., Labrie M., St-Pierre Y. Intracellular galectins in cancer cells: potential new targets for therapy (review). Int. J. Oncol. 2014, 44:1001-1014.
26. Winterbourn C.C. Free-radical production and oxidative reactions of hemoglobin. Environ. Health Perspect. 1985, 64:321-330.
27. Zavodnik I.B., Lapshina E.A., Zavodnik L.B., Soszyński M., Bartosz G., Bryszewska M. Hypochlorous acid-induced oxidative damage of human red blood cells: effects of tert-butyl hydroperoxide and nitrite on the HOCl reaction with erythrocytes. Bioelectrochemistry 2002, 58:127-135.